0

526546

CHOKSILA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

CHOKSI LABORATORIES LTD. Share Price Today

Investment Returns

Over 1 Month -6.14% Over 3 Months 13.11% Over 6 Months -5.30% Over 1 Year -22.42%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

CHOKSI LABORATORIES LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 88.10
  • P/E Ratio (TTM) 44.65
  • Beta 0.58
  • Book Value / share 36.71
  • Return on equity 6.63%
  • EPS (TTM) 2.16
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 1.03
info icon alternate text

CHOKSI LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 12.82
Operating Expense 11.78
Net Profit 1.03
Net Profit Margin (%) 8.03
Earnings Per Share (EPS) 1.47
EBITDA 3.70
Effective Tax Rate (%) 6.36
Particulars DEC 2025 (Values in Cr)
Revenue 10.82
Operating Expense 10.81
Net Profit 0.31
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 0.45
EBITDA 3.54
Effective Tax Rate (%) 65.55
Particulars SEP 2025 (Values in Cr)
Revenue 11.12
Operating Expense 10.57
Net Profit 0.24
Net Profit Margin (%) 2.15
Earnings Per Share (EPS) 0.35
EBITDA 2.94
Effective Tax Rate (%) 57.14
Particulars JUN 2025 (Values in Cr)
Revenue 11.24
Operating Expense 10.62
Net Profit 0.39
Net Profit Margin (%) 3.46
Earnings Per Share (EPS) 0.55
EBITDA 2.91
Effective Tax Rate (%) 38.09
Particulars MAR 2025 (Values in Cr)
Revenue 11.40
Operating Expense 10.18
Net Profit 0.92
Net Profit Margin (%) 8.07
Earnings Per Share (EPS) 1.32
EBITDA 3.54
Effective Tax Rate (%) 26.98
Particulars MAR 2026 (Values in Cr)
Revenue 46.01
Operating Expense 43.78
Net Profit 1.96
Net Profit Margin (%) 4.25
Earnings Per Share (EPS) 2.82
EBITDA 13.10
Effective Tax Rate (%) 38.55
Particulars MAR 2025 (Values in Cr)
Revenue 41.78
Operating Expense 39.69
Net Profit 1.52
Net Profit Margin (%) 3.63
Earnings Per Share (EPS) 2.19
EBITDA 11.30
Effective Tax Rate (%) 29.30
Particulars MAR 2024 (Values in Cr)
Revenue 36.70
Operating Expense 35.19
Net Profit 1.11
Net Profit Margin (%) 3.02
Earnings Per Share (EPS) 1.59
EBITDA 10.37
Effective Tax Rate (%) 33.13
Particulars MAR 2023 (Values in Cr)
Revenue 34.44
Operating Expense 33.19
Net Profit 3.21
Net Profit Margin (%) 9.32
Earnings Per Share (EPS) 4.61
EBITDA 12.71
Effective Tax Rate (%) 13.70
Particulars MAR 2022 (Values in Cr)
Revenue 30.04
Operating Expense 29.80
Net Profit 0.21
Net Profit Margin (%) 0.69
Earnings Per Share (EPS) 0.30
EBITDA 9.01
Effective Tax Rate (%) 43.24
Particulars MAR 2025 (Values in Cr)
Book Value / Share 33.89
ROE % 6.63
ROCE % 8.89
Total Debt to Total Equity 1.31
EBITDA Margin 27.21
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.89
ROE % 5.12
ROCE % 8.58
Total Debt to Total Equity 1.46
EBITDA Margin 28.45
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.31
ROE % 8.41
ROCE % 8.92
Total Debt to Total Equity 1.79
EBITDA Margin 30.43
Particulars MAR 2022 (Values in Cr)
Book Value / Share 25.70
ROE % 1.18
ROCE % 6.29
Total Debt to Total Equity 2.14
EBITDA Margin 30.03
Particulars MAR 2021 (Values in Cr)
Book Value / Share 25.48
ROE % -13.74
ROCE % 0.02
Total Debt to Total Equity 1.86
EBITDA Margin 17.94
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 65.33
Total Liabilities 65.33
Total Equity 23.60
Share Outstanding 0
Price to Book Ratio 3.55
Return on Assets (%) 2.33
Return on Capital (%) 2.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.65
Total Assets 61.95
Total Liabilities 61.95
Total Equity 22.21
Share Outstanding 0
Price to Book Ratio 1.33
Return on Assets (%) 1.79
Return on Capital (%) 2.16
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.33
Total Assets 60.36
Total Liabilities 60.36
Total Equity 21.10
Share Outstanding 0
Price to Book Ratio 1.10
Return on Assets (%) 5.31
Return on Capital (%) 6.24
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 64.41
Total Liabilities 64.41
Total Equity 17.90
Share Outstanding 0
Price to Book Ratio 0.99
Return on Assets (%) 0.32
Return on Capital (%) 0.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 66.38
Total Liabilities 66.38
Total Equity 17.74
Share Outstanding 0
Price to Book Ratio 0.31
Return on Assets (%) -3.92
Return on Capital (%) -4.83
Particulars MAR 2025 (Values in Cr)
Net Income 2.15
Cash from Operations 13.77
Cash from Investing -7.60
Cash from Financing -4.21
Net change in Cash -0.04
Free Cash Flow 21.21
Particulars MAR 2024 (Values in Cr)
Net Income 1.66
Cash from Operations 12.04
Cash from Investing -6.64
Cash from Financing -4.58
Net change in Cash 0.31
Free Cash Flow 16.39
Particulars MAR 2023 (Values in Cr)
Net Income 3.72
Cash from Operations 7.50
Cash from Investing -0.70
Cash from Financing -7.61
Net change in Cash -0.06
Free Cash Flow 11.44
Particulars MAR 2022 (Values in Cr)
Net Income 0.36
Cash from Operations 6.70
Cash from Investing -2.70
Cash from Financing -5.06
Net change in Cash 0.10
Free Cash Flow 7.68
Particulars MAR 2021 (Values in Cr)
Net Income -2.80
Cash from Operations 2.78
Cash from Investing -7.64
Cash from Financing 1.62
Net change in Cash -0.11
Free Cash Flow 10.33
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8471.20 62.27 12.85 121802.86 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.86 23.92 2.88 99.07 40.75 76.00
SHREE PACETRONIX LTD. 132.95 15.87 2.79 49.85 66.10 283.15
TRANSGENE BIOTEK LTD. 3.02 0.00 2.73 22.88 1.83 5.26
VIMTA LABS LIMITED 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8471.20 81.13 12.22 121802.86 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.10 0.00 -9.51 29.21 30.30 57.48
KOVAI MEDICAL CENTER & HO 5840.55 26.14 4.84 6389.56 5010.00 6725.00

CHOKSI LABORATORIES LTD. shareholding pattern

Holding
62.48%
31.48%
6.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

CHOKSI LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
126.50 0.47 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 124.10
  • 26 Days 119.40
  • 10 Days 122.70
  • 50 Days 115.50
  • 12 Days 122.40
  • 100 Days 115.90
  • 20 Days 120.70
  • 200 Days 122.30
124.90 PIVOT
First Support 121.00 First Resistance 129.80 Second Support 116.10 Second Resistance 133.70 Third Support 112.20 Third Resistance 138.60
RSI 57.56 ADX 32.06 MACD 2.98 Williams % R -14.56 Commodity Channel Index (CCI) 19.25
Date 2026-06-22 Week 1404.00 Same Day 297.00 Month 1565.00
1 Year 0.59 3 Year 0.87
Over 1 Month
-6.14% down
Over 1 Year
-22.42% down
Over 3 Months
13.11% down
Over 3 Years
34.75% down
Over 6 Months
-5.30% down
Over 5 Years
57.96% down

CHOKSI LABORATORIES LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Choksi Laboratories Ltd?

Answer Field

Choksi Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 126.50 as on Jun 23 2026 02:48 PM.

What is the Market Cap of Choksi Laboratories Ltd Share?

Answer Field

The market cap of Choksi Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 88.10 as on Jun 23 2026 02:48 PM.

What is the 52 Week High and Low of Choksi Laboratories Ltd?

Answer Field

The 52 Week High and Low of Choksi Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 236.70 and ₹ 81.85.

What is 1 year return for Choksi Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -22.42%.

What is the P/E Ratio of Choksi Laboratories Ltd Share?

Answer Field

As on Jun 23 2026 02:48 PM the price-to-earnings (PE) ratio for Choksi Laboratories Ltd share is 44.65.

What is the PB ratio of Choksi Laboratories Ltd Share?

Answer Field

As on Jun 23 2026 02:48 PM, the price-to-book (PB) ratio for Choksi Laboratories Ltd share is 36.71.

How to Buy Choksi Laboratories Ltd Share?

Answer Field

You can trade in Choksi Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Choksi Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Choksi Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Choksi Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|